FGFR4 CAR T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FGFR4 CAR T Cells, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma [Phase 1]